Lv3
270 积分 2024-01-07 加入
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
11个月前
已完结
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
11个月前
已完结
Buttressing angle of the double-plating fixation of a distal radius fracture: a finite element study
11个月前
已完结
皖公网安备34019202002308
